Answers are grounded in this paper and cite their sources.
Experimental models reveal that inhibition of RORγt reduces inflammation and tumor growth in lung cancer, suggesting a potential therapeutic target.
Supplementary Figure S16. Analysis of IL17A, IL17F, and IL22 promotor methylation and gene expression in LUAD patients.
No takes yet. Share an insight, caveat, or question.
Yamada‐Hara et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: